NVS · Novartis AG · Proposed Sales
$140.77
-4.94 (-3.39%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$276.48B
Shares
1.90B
Volume · Sep 30
2.98M
Avg daily vol (3M)
1.93M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-04-30 | Bulto Carulla Victor | Officer | 6,800 | 2026-04-30 | Fidelity Brokerage Services LLC |
| 2026-02-12 | Marshall Fiona | Officer | 30,743 | 2026-02-12 | Fidelity Brokerage Services LLC |
| 2026-02-09 | Bulto Carulla Victor | Officer | 7,500 | 2026-02-09 | Fidelity Brokerage Services LLC |
| 2025-05-23 | Marshall Fiona | Officer | 15,000 | 2025-05-23 | Fidelity Brokerage Services LLC |
| 2025-04-30 | Kowalski Robert William | Officer | 1,212 | 2025-04-30 | Fidelity Brokerage Services LLC |
| 2024-08-12 | Kowalski Robert William | Officer | 6,566 | 2024-08-12 | Fidelity Brokerage Services LLC |
| 2024-05-22 | Gal Aharon | Officer | 2,500 | 2024-05-22 | The Charles Schwab Corporation |
| 2023-09-19 | Kowalski Robert William | Officer | 1,581 | 2023-09-19 | Fidelity Brokerage Services LLC |
Showing 1–8 of 8 filings
Key facts
CIK
1114448
CUSIP
66987V109
13F (30d)
36 filings
20 filers
Visit website
Investor relations